Skip to content
Search

Latest Stories

Report: Usage of more OTC medicines could save NHS £1.7 billion annually

Approximately 25 million GP appointments and 5 million A&E visits are utilised each year for self-treatable illnesses. If these individuals chose to self-treat using over-the-counter (OTC) medications, the potential savings for NHS could amount to at least £1.7 billion annually, according to a research commissioned by Proprietary Association of Great Britain.

The study, conducted by analysts at Frontier Economics, revealed that embracing self-care could bring an additional economic benefit of £350 million annually, as employees would avoid unnecessary time off from work for medical appointments.


Apart from the savings resulting from the increased OTC medicine use, the report emphasises the potential benefits of reclassifying more prescription-only medications (POMs). A mere 5 per cent reduction in NHS prescribing levels and spending could lead to an annual cost-saving of £1.4 billion, encompassing both prescription costs and GP appointments, it said.

“This substantial amount could greatly alleviate financial pressures on the NHS and offer essential resources for recruiting and training much-needed healthcare professionals.”

PAGB, the representative body for OTC medication manufacturers, emphasises the significance of promoting self-care for common ailments and minor injuries.

“Around 92 per cent of the UK population, that’s 61 million people, use OTCs each year to treat self-treatable conditions, saving the NHS vast sums of money and resource,” said Michelle Riddalls, CEO of PAGB. “We know that the NHS is struggling and as this report clearly demonstrates, if policymakers were to truly embrace the opportunities presented by self-care, the NHS could save an additional £3.1 billion. These vast sums could be saved through greater use of existing OTCs (£1.7 billion) combined with further reclassification of prescription-only medicines (£1.4 billion).”

The report underscores the economic and social advantages of OTC medicines. “With an impressive £8.40 return for every £1 spent on OTCs, the ‘well-being savings’ total a substantial £14.9 billion annually.”

According to the report, these savings stem from avoided work absence, totalling £18 billion and £6.4 billion in NHS prescription and appointment cost savings, respectively. “Additionally, consumers enjoy an estimated £15 billion ‘quality of life benefit’ each year, demonstrating the positive impact of self-care and OTC medicine use on overall well-being.”

However, the report acknowledges that the extent of this increase depends on various factors, including demand, unit costs, patient willingness to switch from prescriptions, and changes in prescribing practices.

In 2022, PAGB members manufactured approximately £4.3 billion worth of OTCs in the UK and exported £2.8 billion worth of OTCs worldwide.

Meanwhile, a recent report by Tony Blair Institute proposes facilitating healthcare provision in pharmacies and other spaces to bring services closer to patients and reduce demands on general practice. The paper 'Modern and Sustainable NHS Providing Accessible and Personalised Care for All' outlines six areas for reform, aiming to transform the future of the NHS and improve patient care.

More For You

Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less